Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

01.01.2024

2 Am J Med
1 Angiology
4 Arterioscler Thromb Vasc Biol
1 Br J Haematol
1 Can J Cardiol
2 Circ J
1 Circ Res
1 Circulation
1 Clin Cardiol
2 Eur Heart J
1 Heart
2 Hypertension
1 Int J Cardiol
1 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
1 J Thorac Cardiovasc Surg
1 JAMA
1 PLoS One



    Am J Med

  1. HOPKINS S, Gajagowni S, Qadeer Y, Wang Z, et al
    Oral health and cardiovascular disease.
    Am J Med. 2023 Dec 21:S0002-9343(23)00755-6. doi: 10.1016/j.amjmed.2023.
    >> Share

  2. YUE Q, Yang L, Liu T, Feng B, et al
    Controlling risk factors reduces cancer risk in patients with atherosclerotic cardiovascular disease: A Cohort Study.
    Am J Med. 2023 Dec 20:S0002-9343(23)00762-3. doi: 10.1016/j.amjmed.2023.
    >> Share


    Angiology

  3. MO DG, Wang MM
    HbA1c/C-Peptide Ratio Is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction.
    Angiology. 2023 Dec 26:33197231225294. doi: 10.1177/00033197231225294.
    >> Share


    Arterioscler Thromb Vasc Biol

  4. GARG PK, Bhatia HS, Allen TS, Grainger T, et al
    Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies.
    Arterioscler Thromb Vasc Biol. 2024;44:24-47.
    >> Share

  5. KAWAI K, Finn AV, Virmani R
    Subclinical Atherosclerosis: Part 1: What Is it? Can it Be Defined at the Histological Level?
    Arterioscler Thromb Vasc Biol. 2024;44:12-23.
    >> Share

  6. WILLIAMS KJ
    Eradicating Atherosclerotic Events by Targeting Early Subclinical Disease: It Is Time to Retire the Therapeutic Paradigm of Too Much, Too Late.
    Arterioscler Thromb Vasc Biol. 2024;44:48-64.
    >> Share

  7. CORNELISSEN A, Gadhoke NV, Ryan K, Hodonsky CJ, et al
    Polygenic Risk Score Associates With Atherosclerotic Plaque Characteristics at Autopsy.
    Arterioscler Thromb Vasc Biol. 2024;44:300-313.
    >> Share


    Br J Haematol

  8. BAECH J, Husby S, Trab T, Kragholm K, et al
    Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study.
    Br J Haematol. 2023 Dec 28. doi: 10.1111/bjh.19272.
    >> Share


    Can J Cardiol

  9. HEMETSBERGER R, Mankerious N, Muntane-Carol G, Temporal J, et al
    In-hospital Outcomes of Rotational Atherectomy in ST-elevation Myocardial Infarction - Results from the Multicenter ROTA-STEMI Network.
    Can J Cardiol. 2023 Dec 24:S0828-282X(23)02034.
    >> Share


    Circ J

  10. TAKASE B, Masaki N, Ikeda T, Shimizu W, et al
    Could Brugada Syndrome Be Treated With Percutaneous Coronary Intervention??- Reply.
    Circ J. 2023;88:178.
    >> Share

  11. LIM PO
    Could Brugada Syndrome Be Treated With Percutaneous Coronary Intervention?
    Circ J. 2023;88:177.
    >> Share


    Circ Res

  12. JULLA JB, Girard D, Diedisheim M, Saulnier PJ, et al
    Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.
    Circ Res. 2023 Dec 28. doi: 10.1161/CIRCRESAHA.123.322757.
    >> Share


    Circulation

  13. TAQUETI VR
    Prevalence of Abnormal Coronary Function in Patients With Angina and No Obstructive Coronary Artery Disease on Coronary Computed Tomography Angiography: Insights From the CorCTA Trial.
    Circulation. 2024;149:24-27.
    >> Share


    Clin Cardiol

  14. WANG C, Liu S, Yang Y, Kamronbek R, et al
    Interleukin-4 and Interleukin-17 are associated with coronary artery disease.
    Clin Cardiol. 2023 Dec 25. doi: 10.1002/clc.24188.
    >> Share


    Eur Heart J

  15. PEDICINO D, Vergallo R
    More blood for patients with myocardial infarction and anaemia?
    Eur Heart J. 2023 Dec 23:ehad832. doi: 10.1093.
    >> Share

  16. TAQUETI VR
    Leveraging global coronary flow assessments to inform revascularization benefit in chronic coronary disease: time to test total heart flow.
    Eur Heart J. 2023 Dec 28:ehad812. doi: 10.1093.
    >> Share


    Heart

  17. BJORKLUND E, Enstrom P, Nielsen SJ, Tygesen H, et al
    Postdischarge major bleeding, myocardial infarction, and mortality risk after coronary artery bypass grafting.
    Heart. 2023 Dec 26:heartjnl-2023-323394. doi: 10.1136/heartjnl-2023-323394.
    >> Share


    Hypertension

  18. CHATURVEDI A, Zhu A, Vaishnavi Gadela N, Prabhakaran D, et al
    Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases.
    Hypertension. 2023 Dec 28. doi: 10.1161/HYPERTENSIONAHA.123.21354.
    >> Share

  19. PETRAK O, Kratka Z, Holaj R, Zitek M, et al
    Cardiovascular Complications in Pheochromocytoma and Paraganglioma: Does Phenotype Matter?
    Hypertension. 2023 Dec 28. doi: 10.1161/HYPERTENSIONAHA.123.21902.
    >> Share


    Int J Cardiol

  20. WU Y, Huang N, Sun T, Zhang B, et al
    Association between normalized lactate load and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Dec 23:131658. doi: 10.1016/j.ijcard.2023.131658.
    >> Share


    J Cardiovasc Pharmacol

  21. SPADAFORA L, Gaudio C, Biondi-Zoccai G, Frati G, et al
    Catalysts of cardiovascular electromechanical harmony? Unveiling the impact of RAS Inhibitors and ARNI on atrial fibrillation recurrence after ablation.
    J Cardiovasc Pharmacol. 2023 Dec 27. doi: 10.1097/FJC.0000000000001537.
    >> Share


    J Clin Endocrinol Metab

  22. GURGOGLIONE FL, Pitocco D, Montone RA, Rinaldi R, et al
    Microvascular complications are associated with coronary collateralization in type 2 diabetes and chronic occlusion.
    J Clin Endocrinol Metab. 2023 Jul 7:dgad396. doi: 10.1210.
    >> Share


    J Thorac Cardiovasc Surg


  23. Discussion to: Unexpected impact of preoperative anemia in low-risk isolated coronary artery bypass grafting or single-valve surgical patients: Do not overlook these patients in anemia management!
    J Thorac Cardiovasc Surg. 2023 Dec 26:S0022-5223(23)01114.
    >> Share


    JAMA

  24. LARKIN H
    What to Know About PREVENT, the AHA's New Cardiovascular Disease Risk Calculator.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25115.
    >> Share


    PLoS One

  25. ZHU W, Ben Y, Shen Y, Liu W, et al
    Vericiguat protects against cardiac damage in a pig model of ischemia/reperfusion.
    PLoS One. 2023;18:e0295566.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016